P

Prism Medico and Pharmacy Limited

PRISMMEDI
Market snapshot · 2026-08-11 00:41 UTC

26.26

₹-0.88 (-3.24%)

MARKET CAP

₹15.92 Cr

STOCK P/E

2,626.0x

52W HIGH

₹34.49

52W LOW

₹13.10

BOOK VALUE

₹25.42

EPS

₹0.01

ROE

2.09%

SECTOR

Consumer Staples

GROSS NPA

0.00%

VOLUME

15,830

P/B RATIO

1.03x

NET NPA

0.00%

Sector

Consumer Staples

Themes

Agro Products
₹32.77₹27.90₹23.03₹18.16₹13.29VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 9.5% above historical median. Valuation is rising — currently in the overvalued zone (z-score: +0.64). Confidence: 76%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Overvalued

5Y Average

Current

2714.00

Overvalued

2793.00

Undervalued

1815.00

EV/EBITDA
Overvalued

5Y Average

28.79

Current

36.47

Overvalued

39.82

Undervalued

16.52

P/S
Overvalued

5Y Average

5.14

Current

6.52

Overvalued

7.11

Undervalued

2.95

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.28 CrMar 2026

Latest net profit

₹-0.24 CrMar 2026

Free cash flow

₹0.00 CrMar 2026

Net Profit

₹-0.24 CrProfit conversion

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-0.55 Cr0.00 Cr0.55 Cr1.10 Cr1.65 Cr
  • Revenue
  • Net income
  • Net margin %

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
Total incomeInterestOtheradjustmentsProfitbefore taxTax &minorityNet Profit-0.30 Cr-0.15 Cr0.00 Cr0.15 Cr0.30 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Debt free
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-6.00 Cr0.00 Cr6.00 Cr12 Cr18 Cr
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue +1.270.000.032.750.150.060.290.210.071.590.500.070.28
Interest0.000.000.000.000.000.000.000.000.000.000.000.000.00
Expenses +1.240.110.092.560.320.150.280.220.060.940.600.090.40
Financing Profit0.03-0.11-0.060.19-0.17-0.090.01-0.010.010.65-0.10-0.02-0.12
Financing Margin %2.36%-200.00%6.91%-113.33%-150.00%3.45%-4.76%14.29%40.88%-20.00%-28.57%-42.86%
Other Income +0.000.020.010.000.100.000.000.000.010.000.020.010.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.03-0.09-0.050.19-0.07-0.090.01-0.010.020.65-0.08-0.01-0.12
Tax %-100.00%0.00%0.00%0.00%-14.29%0.00%0.00%0.00%-100.00%-1.54%0.00%0.00%100.00%
Net Profit +0.05-0.09-0.050.19-0.07-0.090.01-0.010.040.66-0.08-0.01-0.24
EPS in Rs0.08-0.15-0.080.31-0.12-0.150.02-0.020.071.09-0.13-0.02-0.40
Gross NPA %
Net NPA %
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +25.00%25.00%25.00%25.50%29.98%
Public +75.00%75.00%75.01%74.51%70.02%
Jun 2026
Promoters +
Public +

Events Timeline

Board Meeting Intimation for Regulation 29(1) Of SEBI (LODR) Regulations, 2015.

Aug 05, 2026PDFCompany Reports Open

Undertaking Of Functional Website.

Jul 30, 2026PDFCompany Reports Open

Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

Jul 21, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 13, 2026PDFCompany Reports Open

Compliance-57 (5) : intimation after the end of quarter

Jul 06, 2026PDFCompany Reports Open